Innovative Clinical Tech Deep 6 AI's cutting-edge use of artificial intelligence and natural language processing to accelerate patient recruitment offers a compelling value proposition for healthcare organizations and pharma companies seeking to streamline clinical trial enrollment and reduce time-to-market.

Strategic Industry Partnerships Recent collaborations with Graticule and Bio Optronics demonstrate Deep 6 AI’s ability to expand its data integration capabilities and enhance real-world evidence offerings, making it a valuable partner for organizations looking to leverage advanced data analytics in clinical research.

Robust Funding & Growth With over $27 million in funding and a revenue range of $10 to $25 million, Deep 6 AI shows strong financial backing and growth potential, indicating readiness for scaling solutions and investing in product development to meet increasing market demand.

Recent Acquisition The acquisition by Tempus Inc. significantly broadens Deep 6 AI’s network to encompass more than 750 provider locations and access to millions of patients, presenting opportunities for sales of integrated solutions across extensive healthcare provider networks.

Market Positioning Operating in the competitive clinical research technology space alongside industry giants like IQVIA and Parexel, Deep 6 AI’s focus on data-driven patient matching positions it as a targeted solution for organizations aiming to improve trial efficiency and patient diversity.